Summary

Market Size & Trends

The U.S. equine artificial insemination market size was estimated at USD 155.44 million in 2024 and is projected to reach USD 247.83 million by 2033, growing at a CAGR of 5.41% from 2025 to 2033. The market is continuously growing, driven by the rising popularity of performance and recreational horses, expanding equine veterinary infrastructure, and a supportive regulatory and breeding industry ecosystem. The professional racing and competition, the growing popularity of recreational riding, show jumping, and Western performance events, are driving demand for high-quality horses in the U.S. The U.S. is home to around 9.2 million horses, playing a vital role in recreation, competition, and the broader equine industry. Among this population, nearly 3.9 million are engaged in recreational activities, while about 2.7 million participate in horse shows, reflecting the strong cultural and economic importance of equestrian pursuits nationwide.

Owners are increasingly investing in artificial insemination (AI) to secure foals with superior genetics for endurance, agility, and temperament. This demand spans disciplines such as rodeo, barrel racing, hunter/jumper circuits, and dressage. By enabling wider access to proven stallions, AI supports the breeding of horses suited to diverse performance needs. The expanding recreational equine sector, particularly in states like Texas, Kentucky, and California, continues to boost AI adoption.

U.S. Equine Artificial Insemination Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. equine artificial insemination market report based on solution, equine, and distribution channel:

• Solution Outlook (Revenue, USD Million, 2021 - 2033)
• Equipment & Consumables
• Semen
o Normal Semen
o Sexed Semen
• Services
• Equine Outlook (Revenue, USD Million, 2021 - 2033)
• Sports/Racing
• Recreation
• Other Type
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Private
• Public

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.3.6. Data analysis model
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Equine Artificial Insemination Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding equine veterinary infrastructure
3.2.1.2. Rising popularity of performance and recreational horses
3.2.1.3. Supportive regulatory and breeding industry ecosystem
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced reproductive procedures.
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. U.S. Equine Artificial Insemination Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Legal landscape
3.3.2.3. Economic landscape
3.3.2.4. Social landscape
3.3.2.5. Technological landscape
3.3.2.6. Environmental landscape
3.4. Pricing Analysis
3.5. Regulatory Framework
3.6. Estimated Equine Population by key countries, 2024
Chapter 4. U.S. Equine Artificial Insemination Market: Solution Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Equine Artificial Insemination Market: Solution Movement Analysis
4.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by solution, 2021 to 2033 (USD Million)
4.4. Equipment & Consumables
4.4.1. Equipment & Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Semen
4.5.1. Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.1.1. Normal Semen
4.5.1.1.1. Normal Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.1.2. Sexed Semen
4.5.1.2.1. Sexed Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Services
4.6.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Equine Artificial Insemination Market: Equine Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Equine Artificial Insemination Market: Equine Movement Analysis
5.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by Equine, 2021 to 2033 (USD Million)
5.4. Sports/Racing
5.4.1. Sports/Racing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Recreation
5.5.1. Recreation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Equine Artificial Insemination Market: By Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Equine Artificial Insemination Market: By Distribution Channel Movement Analysis
6.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
6.3.1. Private
6.3.1.1. Private Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.2. Public
6.3.2.1. Public Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Company Market Position Analysis/ Heat Map Analysis
7.3. Company Profiles
7.3.1. Neogen Corporation
7.3.1.1. Participant’s Overview
7.3.1.2. Financial Performance
7.3.1.3. Product/Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Zoetis Services LLC
7.3.2.1. Participant’s Overview
7.3.2.2. Financial Performance
7.3.2.3. Product/Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. HOFFMAN A.I. BREEDERS INC
7.3.3.1. Participant’s Overview
7.3.3.2. Financial Performance
7.3.3.3. Product/Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. Nasco Healthcare
7.3.4.1. Participant’s Overview
7.3.4.2. Financial Performance
7.3.4.3. Product/Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. IMV Technologies
7.3.5.1. Participant’s Overview
7.3.5.2. Financial Performance
7.3.5.3. Product/Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Continental Genetics, LLC
7.3.6.1. Participant’s Overview
7.3.6.2. Financial Performance
7.3.6.3. Product/Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Olympia Equine Veterinary Services PLLC
7.3.7.1. Participant’s Overview
7.3.7.2. Financial Performance
7.3.7.3. Product/Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Sarasota Equine Veterinary Services
7.3.8.1. Participant’s Overview
7.3.8.2. Financial Performance
7.3.8.3. Product/Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Montana Equine Medical and Surgical Center
7.3.9.1. Participant’s Overview
7.3.9.2. Financial Performance
7.3.9.3. Product/Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. Select Breeders Services
7.3.10.1. Participant’s Overview
7.3.10.2. Financial Performance
7.3.10.3. Product/Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Equine Reproduction Concepts, LLC
7.3.11.1. Participant’s Overview
7.3.11.2. Financial Performance
7.3.11.3. Product/Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Wisconsin Valley Veterinary Service
7.3.12.1. Participant’s Overview
7.3.12.2. Financial Performance
7.3.12.3. Product/Service Benchmarking
7.3.12.4. Strategic Initiatives
7.4. Strategy Mapping
7.4.1. Mergers & Acquisitions
7.4.2. Partnerships & Collaborations
7.4.3. Product/Service launch
7.4.4. Others
7.5. List of other key players

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List of secondary sources
Table 2 U.S. Equine Artificial Insemination Market, by Solution, 2021 - 2033 (USD Million)
Table 3 U.S. Equine Artificial Insemination Market, by Equine, 2021 - 2033 (USD Million)
Table 4 U.S. Equine Artificial Insemination Market, by Distribution Channel, 2021 - 2033 (USD Million)
Table 5 Company Overview
Table 6 Product Benchmarking
Table 7 Financial Performance
Table 8 Strategic InitiativesList of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. Equine Artificial Insemination Market revenue, 2021 - 2033 (USD Million)
Fig. 10 U.S. Equine Artificial Insemination Market snapshot
Fig. 11 U.S. Equine Artificial Insemination Market driver impact
Fig. 12 U.S. Equine Artificial Insemination Market restraint impact
Fig. 13 U.S. Equine Artificial Insemination species key takeaways (USD Million)
Fig. 14 U.S. Equine Artificial Insemination Market: solution, market share 2024 & 2033
Fig. 15 U.S. Equipment & Consumables market, 2021 - 2033 (USD Million)
Fig. 16 Semen market, 2021 - 2033 (USD Million)
Fig. 17 Normal market, 2021 - 2033 (USD Million)
Fig. 18 Sexed market, 2021 - 2033 (USD Million)
Fig. 19 Services market, 2021 - 2033 (USD Million)
Fig. 20 U.S. Equine Artificial Insemination equine key takeaways (USD Million)
Fig. 21 U.S. Equine Artificial Insemination Market: equine, market share 2024 & 2033
Fig. 22 Sports/Racing market, 2021 - 2033 (USD Million)
Fig. 23 Recreation market, 2021 - 2033 (USD Million)
Fig. 24 Others market, 2021 - 2033 (USD Million)
Fig. 25 U.S. Equine Artificial Insemination market by Distribution Channel: Key takeaways
Fig. 26 U.S. Equine Artificial Insemination market by Distribution Channel, market share, 2024 & 2033
Fig. 27 Private market, 2021 - 2033 (USD Million)
Fig. 28 Public market, 2021 - 2033 (USD Million)
Fig. 29 Market participant categorization
Fig. 30 Market share of key market players U.S. Equine Artificial Insemination market